SWEDISH ORPHAN/S (OTCMKTS:SWTUY) Stock Price Down 1.2% – Time to Sell?

SWEDISH ORPHAN/S (OTCMKTS:SWTUY)’s share price was down 1.2% on Tuesday . The stock traded as low as $24.38 and last traded at $24.38. 200 shares changed hands during trading, a decline of 88% from the average daily volume of 1,665 shares. The stock had previously closed at $24.67.

SWEDISH ORPHAN/S Price Performance

The firm has a market cap of $6.64 billion, a price-to-earnings ratio of 48.76, a price-to-earnings-growth ratio of 1.30 and a beta of 1.81. The business’s 50-day moving average price is $24.38 and its two-hundred day moving average price is $24.38.

SWEDISH ORPHAN/S Company Profile

Swedish Orphan Biovitrum AB, known as Sobi, is a Sweden-based specialty pharmaceutical company focused on developing, manufacturing and commercializing medicines for rare diseases. The company’s primary therapeutic areas include hematology, immunology and other conditions with significant unmet medical needs.

Sobi’s portfolio includes treatments for inherited and acquired blood disorders, immune-mediated diseases and related specialty-care conditions. Its products and development programs are distributed across international markets, with commercial activities spanning Europe, North America and selected regions in the Middle East, Asia and other global markets.

The company traces its roots to Swedish pharmaceutical operations established in the 1930s and adopted its current name after Swedish Orphan International combined with Biovitrum in 2010.